Flash FinanceUS
Market open S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Addus HomeCare (ADUS)

Addus HomeCare completes $350 million acquisition of Gentiva personal care business

Neutral Impact 4 of 5 m&a Written later

Addus HomeCare Corporation said its subsidiary completed the purchase of the personal care business of Curo Health Services, which does business as Gentiva, on December 2, 2024. The cash price was $350 million, subject to customary adjustments, and the deal adds operations in seven states, including Texas and Missouri, where the company says it will become the largest personal care provider in Texas. The filing does not include financial results for the acquired business, and the company's financial statements for the deal will be filed by amendment.

Key points

  • Purchase price: $350 million in cash, subject to customary working capital and other adjustments
  • Company states the acquired business adds annualized revenues of approximately $280 million
  • Funded through the existing revolving credit facility and part of the proceeds of a June 28, 2024 public offering of common stock
  • Operations in Arizona, Arkansas, California, Missouri, North Carolina, Tennessee and Texas; acquired financial statements and pro forma information to follow by amendment

The filing

CompanyAddus HomeCare (ADUS)
Form8-K, current report
Filed with the SECDec 2, 2024, 4:34 PM ET
Accession number0001193125-24-268958

Items reported: 2.01 Acquisition or Disposition Completed7.01 Regulation FD Disclosure

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 6:56 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on December 02, 2024.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.